Virginia Commonwealth University at ObesityWeek 2026

Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website

Virginia Commonwealth University brings 3 presentations to ObesityWeek 2026 in National Harbor. Its sessions cover obesity treatment and food policy for families, from medication to home-based care for children. They include the long-term effectiveness of phentermine in the LEAP trial and parents' views on upcoming SNAP limits on sweetened beverages in Virginia.

OrganizationObesityWeek 2026 Attendance
Universities & research institutes
Public research university in Richmond, Virginia, with a school of medicine.
Session
Mon Nov 16
8:30am–9:30am
LEAP Trial: Long-Term Effectiveness of the Obesity Medication Phentermine
Presents results of LEAP, the first 24-month placebo-controlled trial of the widely used obesity drug phentermine, covering effectiveness, heart risk and safety.
Woodrow Wilson, Ballroom Level
Interventional and clinical studiesClinical obesity care and professional practicePolicy and public healthObesity pharmacotherapy and drug developmentChronic disease and obesity complications

Explore the full ObesityWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in National Harbor. Leave your work email and we’ll be in touch.

Privacy

Download the full ObesityWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Virginia Commonwealth University

Tell us what you sell and we’ll find the people at Virginia Commonwealth University most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction